首页 › 基金 › Fortress Investment Group LLC › RNA
Fortress Investment Group LLC 对 RNA 的持仓历史
ATRIUM THERAPEUTICS INC · 医疗保健
Fortress Investment Group LLC 在 Q3 2026 的 13F 申报中披露持有 RNA(ATRIUM THERAPEUTICS INC)20,000 股,市值约 US$166K,约占其申报组合的 0.03%,在其申报持仓中市值排名第 24 位。 Fortress Investment Group LLC 最近 3 个申报季度中有 2 个季度披露了 RNA 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Fortress Investment Group LLC 对 RNA 的持仓演变
Fortress Investment Group LLC 于 Q1 2026 首次披露 RNA 持仓:22,033 股(约 US$295K)。 在 2 次申报中,Fortress Investment Group LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 20,000 股、市值约 US$166K。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 22.03K | $294.58K | 新进 |
| Q3 2026 | 20.00K | $165.60K | 新进 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RNA 与 13F 数据
RNA(ATRIUM THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 88 只申报持有 RNA,申报仓位最大的包括:Sessa Capital IM, L.P. (US$20.2M), TIG Advisors, LLC (US$7.6M), O'Connor Alternative Investments LLC (US$4.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RNA 的基金
- Sessa Capital IM, L.P. 1.50M 股 · $20.18M · Q2 2026
- TIG Advisors, LLC 561.53K 股 · $7.55M · Q2 2026
- O'Connor Alternative Investments LLC 559.14K 股 · $4.63M · Q3 2026
- Bracebridge Capital, LLC 524.48K 股 · $4.34M · Q3 2026
- Arbiter Partners Capital Management LLC 311.72K 股 · $2.58M · Q3 2026
- NEXPOINT ASSET MANAGEMENT, L.P. 150.03K 股 · $2.02M · Q2 2026
- Kalehua Capital Management LLC 112.65K 股 · $932.76K · Q3 2026
- Athos Capital Ltd 107.97K 股 · $894.00K · Q3 2026
- Marble Bar Asset Management LLP 103.90K 股 · $860.27K · Q3 2026
- Trium Capital LLP 58.38K 股 · $483.40K · Q3 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 43.76K 股 · $362.32K · Q3 2026
- Slotnik Capital, LLC 39.93K 股 · $330.62K · Q3 2026
更多关于 Fortress Investment Group LLC
常见问题
How long has Fortress Investment Group LLC held RNA?
Fortress Investment Group LLC has disclosed RNA holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
What is Fortress Investment Group LLC's current position in RNA?
As of Q3 2026, Fortress Investment Group LLC holds 20.00K shares of RNA (ATRIUM THERAPEUTICS INC), valued at $165.60K, representing 0.03% of its reported portfolio and ranking #24.
Has Fortress Investment Group LLC been buying or selling RNA?
In the latest 13F filing (Q3 2026), Fortress Investment Group LLC newly opened its position in RNA.
Which other funds hold RNA?
Other major institutional holders of RNA include Sessa Capital IM, L.P., TIG Advisors, LLC, O'Connor Alternative Investments LLC, among 88 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.